#RBQMLive
RBQM 2024 On-Demand
Day One Sessions
Day Two Sessions
Keynote: Unlocking the Path to RBQM Maturity
Speaker: Ken Getz, Executive Director and Professor, Tufts Center for the Study of Drug Development
- Explore evidence-based insights on the evolution of RBQM adoption
- Uncover factors driving and hindering the journey towards RBQM usage maturity
- Gain actionable insights from recent empirical research findings
Panel: Taking RBQM into New Dimensions – Understanding the Risk-Based Data Management (RBDM) Revolution
Speakers:
Miguel Valenzuela, Associate Director of Clinical Operations, RBQM, Alnylam
Paul MacDonald, Senior Director Vault CDMS Strategy at VeevaPanel
Patrick Nadonly, Global Head, Clinical Data Management, Sanofi
Miguel Valenzuela, Associate Director of Clinical Operations, RBQM, Alnylam
Paul MacDonald, Senior Director Vault CDMS Strategy at VeevaPanel
Patrick Nadonly, Global Head, Clinical Data Management, Sanofi
- Explore how RBQM identifies real-time “outliers,” such as training deficiencies or fraud, and enables prompt corrective action
- Integrated data review: Explore the integration of RBQM and RBDM to ensure comprehensive risk management
- Gain insights into real-world applications of integrated data review and data quality oversight
Panel: The Emergence of AI & ML in RBQM: What’s here now and what is to come?
Speakers:
Marcin Makowski, Head of Centralized Monitoring & Data Analytics, GSK
Bob Zambon, Vice President, Growth Solutions & Technology Enablement, Syneos Health
Marcin Makowski, Head of Centralized Monitoring & Data Analytics, GSK
Bob Zambon, Vice President, Growth Solutions & Technology Enablement, Syneos Health
- Explore real-world applications of AI & ML in RBQM
- Discover how AI-driven machine-learning can revolutionize data analysis for increased efficiency
- Learn key insights into the evolving AI & ML landscape and the research-backed benefits of AI & ML in RBQM
Panel: RBQM Industry Guidance Evolution – Adapting to Modernization
Speakers:
Olivia Feiro, Director, Risk Management & Analytics, CSL Behring
Lotte Smets, Director Data Management, Julius Clinical
Daniel DiJohnson, Risk-Based Quality Management SME, Senior Manager, Parexel
Olivia Feiro, Director, Risk Management & Analytics, CSL Behring
Lotte Smets, Director Data Management, Julius Clinical
Daniel DiJohnson, Risk-Based Quality Management SME, Senior Manager, Parexel
- Discuss opportunities and challenges with evolving guidance updates
- Understand strategies for integrating quality by design into clinical trial design and execution
- Examine approaches to ensure inspection readiness
Enhancing Data Quality through Advanced Audit Trail Review
Speakers:
Paola Peshkepija, Senior Associate Central Monitor, Pfizer
Jennifer Nielsen, Senior Specialist, Clinical Data Management, Lundbeck
Paola Peshkepija, Senior Associate Central Monitor, Pfizer
Jennifer Nielsen, Senior Specialist, Clinical Data Management, Lundbeck
- Explore the role of audit trail review in detecting risks and improving data quality
- Gain insights into detecting anomalies in various audit trail data sources
- Use case: Uncover how audit trail data helped detect risks in data quality
Panel: Integrated Data Review: Optimizing Study Oversight
Speakers:
Brian Barnes, Director of Risk Management Strategy – Process Excellence & Oversight, BioNTech
Jess Thompson, Founder, Clinical Research Project Management Association
Alaine Heffernan, Director Centralized Monitoring, Allucent
Brian Barnes, Director of Risk Management Strategy – Process Excellence & Oversight, BioNTech
Jess Thompson, Founder, Clinical Research Project Management Association
Alaine Heffernan, Director Centralized Monitoring, Allucent
- Best practices for leveraging technology to facilitate data review
- Access the right data at the right time for informed decision-making
- Gaining insights into effective collaboration strategies for study oversight